April 20, 2014 2:35 PM ET


Company Overview of Hybritech, Inc.

Company Overview

Hybritech, Inc., a biotechnology company, develops, and markets monoclonal antibodies which are used in making diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases including colon and prostate cancer, infertility, allergies, and pregnancy. The company was founded in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Beckman Coulter, Inc.

PO Box 269006

San Diego, CA 92196-9006

United States

Founded in 1978





Key Executives for Hybritech, Inc.

Hybritech, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
BioQuanta Corp. United States
Heliae Development, LLC United States
NEONC Technologies, Inc. United States
Adjuvance Technologies, Inc. United States
Cerco Medical, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Hybritech, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.